Literature DB >> 33129738

In Search of the Holy Grail: Evidence of Amyloid Fibril Regression in ATTR Cardiac Amyloidosis.

Frederick L Ruberg1, Omar K Siddiqi2.   

Abstract

Entities:  

Keywords:  ATTR; amyloidosis; cardiac magnetic resonance imaging

Mesh：

Substances：

Year:  2020        PMID： 33129738      PMCID： PMC8543316          DOI： 10.1016/j.jcmg.2020.08.021

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN： 1876-7591


× No keyword cloud information.
  14 in total

Review 1.  Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.

Authors:  Frederick L Ruberg; Martha Grogan; Mazen Hanna; Jeffery W Kelly; Mathew S Maurer
Journal:  J Am Coll Cardiol       Date:  2019-06-11       Impact factor: 24.094

2.  Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis.

Authors:  Scott D Solomon; David Adams; Arnt Kristen; Martha Grogan; Alejandra González-Duarte; Mathew S Maurer; Giampaolo Merlini; Thibaud Damy; Michel S Slama; Thomas H Brannagan; Angela Dispenzieri; John L Berk; Amil M Shah; Pushkal Garg; Akshay Vaishnaw; Verena Karsten; Jihong Chen; Jared Gollob; John Vest; Ole Suhr
Journal:  Circulation       Date:  2019-01-22       Impact factor: 29.690

Review 3.  Systemic amyloidosis.

Authors:  Ashutosh D Wechalekar; Julian D Gillmore; Philip N Hawkins
Journal:  Lancet       Date:  2015-12-21       Impact factor: 79.321

4.  Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac Amyloidosis.

Authors:  Graham Lohrmann; Alexandra Pipilas; Roberta Mussinelli; Deepa M Gopal; John L Berk; Lawreen H Connors; Nirupama Vellanki; Jennifer Hellawell; Omar K Siddiqi; Jonathan Fox; Mathew S Maurer; Frederick L Ruberg
Journal:  J Card Fail       Date:  2019-12-02       Impact factor: 5.712

5.  Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.

Authors:  Merrill D Benson; Márcia Waddington-Cruz; John L Berk; Michael Polydefkis; Peter J Dyck; Annabel K Wang; Violaine Planté-Bordeneuve; Fabio A Barroso; Giampaolo Merlini; Laura Obici; Morton Scheinberg; Thomas H Brannagan; William J Litchy; Carol Whelan; Brian M Drachman; David Adams; Stephen B Heitner; Isabel Conceição; Hartmut H Schmidt; Giuseppe Vita; Josep M Campistol; Josep Gamez; Peter D Gorevic; Edward Gane; Amil M Shah; Scott D Solomon; Brett P Monia; Steven G Hughes; T Jesse Kwoh; Bradley W McEvoy; Shiangtung W Jung; Brenda F Baker; Elizabeth J Ackermann; Morie A Gertz; Teresa Coelho
Journal:  N Engl J Med       Date:  2018-07-05       Impact factor: 91.245

6.  Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial.

Authors:  John L Berk; Ole B Suhr; Laura Obici; Yoshiki Sekijima; Steven R Zeldenrust; Taro Yamashita; Michael A Heneghan; Peter D Gorevic; William J Litchy; Janice F Wiesman; Erik Nordh; Manuel Corato; Alessandro Lozza; Andrea Cortese; Jessica Robinson-Papp; Theodore Colton; Denis V Rybin; Alice B Bisbee; Yukio Ando; Shu-ichi Ikeda; David C Seldin; Giampaolo Merlini; Martha Skinner; Jeffery W Kelly; Peter J Dyck
Journal:  JAMA       Date:  2013-12-25       Impact factor: 56.272

7.  Cardiac Amyloid Load: A Prognostic and Predictive Biomarker in Patients With Light-Chain Amyloidosis.

Authors:  Arnt V Kristen; Eva Brokbals; Fabian Aus dem Siepen; Ralf Bauer; Selina Hein; Matthias Aurich; Johannes Riffel; Hans-Michael Behrens; Sandra Krüger; Peter Schirmacher; Hugo A Katus; Christoph Röcken
Journal:  J Am Coll Cardiol       Date:  2016-07-05       Impact factor: 24.094

8.  CMR-Verified Regression of Cardiac AL Amyloid After Chemotherapy.

Authors:  Ana Martinez-Naharro; Amna Abdel-Gadir; Thomas A Treibel; Giulia Zumbo; Daniel S Knight; Stefania Rosmini; Thirusha Lane; Shameem Mahmood; Sajitha Sachchithanantham; Carol J Whelan; Helen J Lachmann; Ashutosh D Wechalekar; Peter Kellman; Julian D Gillmore; James C Moon; Philip N Hawkins; Marianna Fontana
Journal:  JACC Cardiovasc Imaging       Date:  2017-04-12

9.  Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.

Authors:  Mathew S Maurer; Jeffrey H Schwartz; Balarama Gundapaneni; Perry M Elliott; Giampaolo Merlini; Marcia Waddington-Cruz; Arnt V Kristen; Martha Grogan; Ronald Witteles; Thibaud Damy; Brian M Drachman; Sanjiv J Shah; Mazen Hanna; Daniel P Judge; Alexandra I Barsdorf; Peter Huber; Terrell A Patterson; Steven Riley; Jennifer Schumacher; Michelle Stewart; Marla B Sultan; Claudio Rapezzi
Journal:  N Engl J Med       Date:  2018-08-27       Impact factor: 91.245

Review 10.  Cardiac Amyloidosis: Updates in Imaging.

Authors:  Liza Chacko; Raffaele Martone; Francesco Cappelli; Marianna Fontana
Journal:  Curr Cardiol Rep       Date:  2019-08-02       Impact factor: 2.931
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.